G immunoglobulin used against anthrax toxins

Details for Australian Patent Application No. 2008332943 (hide)

Owner LFB-Biotechnologies Etat Francais Represente Par Le Delegue General Pour L'Armement

Inventors Behrens, Christian; Thullier, Philippe

Agent Watermark

Pub. Number AU-A-2008332943

PCT Pub. Number WO2009/071860

Priority 0759419 29.11.07 FR

Filing date 28 November 2008

Wipo publication date 11 June 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/071860 Priority application(s): WO2009/071860

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008332955-Improved aqueous-based wellbore fluids

2008332930-Wound management